Mast cells, which are abundant in the airways of asthmatic individuals, act as first responders to viral infections by ...

This oral drug is a potent and highly selective inhibitor that targets KIT D816V ... Over 90% of patients achieved at least 50% reduction in mast cell burden as measured by laboratory and bone ...

Discover 8 ways mast cell activation syndrome causes widespread symptoms from digestive issues to brain fog, often mistaken ...

This hormone treats anaphylaxis. Proton pump inhibitors. These medicines curb stomach acid, which may ease some of the digestion problems you may get. Mast cell stabilizers. These drugs ...

underscoring the importance of treating patients early in the ISM disease course -- -- BLU-808 healthy volunteer trial results demonstrate wide therapeutic window for modulating mast cell activity ...

At the recent AAAAI/WAO meeting, Blueprint Medicines Corp. presented the in vitro and in vivo characterization of BLU-808, a selective inhibitor of wild-type KIT, a transmembrane receptor tyrosine ...

The global mast cell tumor treatment market is on a strong growth trajectory, with market projections estimating a valuation of USD 7,836.4 million by 2034. This reflects a steady CAGR of 3.4% from ...

Detailed price information for Celldex Therapeutics (CLDX-Q) from The Globe and Mail including charting and trades.